UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION
Inhibitors of the renin-angiotensin-aldosterone system, statins, and possibly , ω-3 polyunsaturated fatty acids may influence the incidence of atrial fibrillation (AF), and can be used to prevent it. In recent medical literature, this approach is referred to as upstream treatment. The results of exp...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2015-12-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/501 |
_version_ | 1797232389312741376 |
---|---|
author | E. A. Protasova N. V. Furman O. V. Reshet'ko |
author_facet | E. A. Protasova N. V. Furman O. V. Reshet'ko |
author_sort | E. A. Protasova |
collection | DOAJ |
description | Inhibitors of the renin-angiotensin-aldosterone system, statins, and possibly , ω-3 polyunsaturated fatty acids may influence the incidence of atrial fibrillation (AF), and can be used to prevent it. In recent medical literature, this approach is referred to as upstream treatment. The results of experiments and clinical studies show that the use of these drugs may be useful for AF primary prevention in certain categories of patients. Nevertheless, there are currently no sufficient evidences to justify these recommendations and apply them to a wider range of patients with AF risk factors. Thus, it is reasonable to continue studies on both primary and secondary AF prevention. |
first_indexed | 2024-03-08T14:05:10Z |
format | Article |
id | doaj.art-9a0b4791df1047b89b50143fd1349df3 |
institution | Directory Open Access Journal |
issn | 1819-6446 2225-3653 |
language | English |
last_indexed | 2024-04-24T15:59:30Z |
publishDate | 2015-12-01 |
publisher | Столичная издательская компания |
record_format | Article |
series | Рациональная фармакотерапия в кардиологии |
spelling | doaj.art-9a0b4791df1047b89b50143fd1349df32024-04-01T07:43:25ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-12-018456156810.20996/1819-6446-2012-8-4-561-568501UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTIONE. A. Protasova0N. V. Furman1O. V. Reshet'ko2Saratov Research Institute for CardiologySaratov Research Institute for CardiologySaratov State Medical University named after V.I. RazumovskyInhibitors of the renin-angiotensin-aldosterone system, statins, and possibly , ω-3 polyunsaturated fatty acids may influence the incidence of atrial fibrillation (AF), and can be used to prevent it. In recent medical literature, this approach is referred to as upstream treatment. The results of experiments and clinical studies show that the use of these drugs may be useful for AF primary prevention in certain categories of patients. Nevertheless, there are currently no sufficient evidences to justify these recommendations and apply them to a wider range of patients with AF risk factors. Thus, it is reasonable to continue studies on both primary and secondary AF prevention.https://www.rpcardio.online/jour/article/view/501atrial fibrillationprevention |
spellingShingle | E. A. Protasova N. V. Furman O. V. Reshet'ko UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION Рациональная фармакотерапия в кардиологии atrial fibrillation prevention |
title | UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION |
title_full | UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION |
title_fullStr | UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION |
title_full_unstemmed | UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION |
title_short | UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION |
title_sort | up to day possibilities of atrial fibrillation prevention |
topic | atrial fibrillation prevention |
url | https://www.rpcardio.online/jour/article/view/501 |
work_keys_str_mv | AT eaprotasova uptodaypossibilitiesofatrialfibrillationprevention AT nvfurman uptodaypossibilitiesofatrialfibrillationprevention AT ovreshetko uptodaypossibilitiesofatrialfibrillationprevention |